What happened
Novo Nordisk will partner with Anthropic to speed up drug development. The Danish drugmaker, which from this week will be known simply as "Novo," is playing catch up after its shares plunged 20% in the past year.
Why it matters
The company is betting AI will help it regain lost market share, after its Ozempic injectable had earlier given it a lead in GLP-1 drugs.
What to watch
The test is whether the partnership actually yields new drugs, since Novo rivals have so far used AI mainly for workplace productivity and designing clinical trials, not discovery.
WHO IT HITSPharmaceutical research and development teams at Novo will be the first to work with Anthropic's technology, while investors watching the company's effort to recover lost GLP-1 market share will judge whether the bet pays off.
Summaries like this, in your inbox every morning.
Novo Nordisk's move to work with Anthropic comes as the company tries to recover from a difficult stretch. Its shares have plunged 20% in the past year, and the firm has launched a culture shake-up. The partnership is a bet that AI can do more than the productivity and clinical-trial design work that rivals have pursued so far, and instead help discover new drugs. Novo had earlier jumped out to a lead with its Ozempic injectable, which became synonymous with GLP-1s. Now, having lost ground, it is looking to AI as a way to close the gap. Whether the effort succeeds will likely hinge on whether the partnership produces actual new drugs, something that has yet to be demonstrated by others in the industry.
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
On September 16, NVIDIA, Google and Emerald AI launched the AI Energy Management Alliance (AEMA), joined by 18…
Britain's royal household announced that King Charles hosted an AI summit at Dumfries House on September 17, d…
Shiseido Japan's AI agent for ingredient discovery cut search time by 95% and increased proposed ingredient ca…
Microsoft is phasing in a consolidation of its Microsoft 365 Copilot app and experience into Microsoft Copilot…
Palantir Technologies drew fresh focus after AI-focused partnerships with Method Security, NVIDIA and Nebius…
Goldman Sachs economists said surging exports of high-end equipment for AI data centers are set to drive GDP g…
